Dimensional Fund Advisors LP Macrogenics Inc Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Macrogenics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 882,660 shares of MGNX stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

882,660

Previous 898,497 1.76%

Holding current value

$3.15 Million

Previous $3.82 Million 23.97%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.0 - $5.55 $47,511 - $87,895	-15,837 Reduced 1.76%	882,660 $2.9 Million
Q2 2024 Aug 09, 2024	SELL	$3.31 - $18.51 $505,642 - $2.83 Million	-152,762 Reduced 14.53%	898,497 $3.82 Million
Q1 2024 May 10, 2024	SELL	$9.77 - $21.47 $1.6 Million - $3.51 Million	-163,641 Reduced 13.47%	1,051,259 $15.5 Million
Q4 2023 Feb 07, 2024	SELL	$4.48 - $10.11 $28,425 - $64,147	-6,345 Reduced 0.52%	1,214,900 $11.7 Million
Q3 2023 Nov 09, 2023	SELL	$4.48 - $6.19 $80,953 - $111,853	-18,070 Reduced 1.46%	1,221,245 $5.69 Million
Q2 2023 Aug 09, 2023	BUY	$4.62 - $7.54 $799,315 - $1.3 Million	173,012 Added 16.23%	1,239,315 $6.63 Million
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $1.5 Million - $2.25 Million	310,479 Added 41.08%	1,066,303 $7.65 Million
Q4 2022 Feb 09, 2023	BUY	$3.34 - $6.98 $954,341 - $1.99 Million	285,731 Added 60.78%	755,824 $5.07 Million
Q3 2022 Nov 10, 2022	SELL	$3.01 - $5.22 $1.34 Million - $2.33 Million	-445,801 Reduced 48.67%	470,093 $1.63 Million
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $550,030 - $2.44 Million	-244,458 Reduced 21.07%	915,894 $2.7 Million
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $613,254 - $1.28 Million	-75,524 Reduced 6.11%	1,160,352 $10.2 Million
Q4 2021 Feb 09, 2022	BUY	$15.91 - $21.88 $298,980 - $411,168	18,792 Added 1.54%	1,235,876 $19.8 Million
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $1.21 Million - $1.76 Million	-61,220 Reduced 4.79%	1,217,084 $25.5 Million
Q2 2021 Aug 12, 2021	BUY	$20.49 - $35.63 $3.4 Million - $5.92 Million	166,071 Added 14.93%	1,278,304 $34.3 Million
Q1 2021 May 14, 2021	SELL	$18.99 - $33.2 $2.14 Million - $3.74 Million	-112,615 Reduced 9.19%	1,112,233 $35.4 Million
Q4 2020 Feb 25, 2021	BUY	$19.41 - $26.0 $23.8 Million - $31.8 Million	1,224,848 New	1,224,848 $28 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $219M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Macrogenics Inc Transaction History